LoginRegister

    GSK fights bid to strike new Zofran preemption evidence

    Medical Dialogues BureauWritten by Medical Dialogues Bureau   |  

    U.S. District Judge F. Dennis Saylor during a hearing in Boston asked why some of GSK's witnesses should be allowed to put forward new opinions to support the drugmaker's defence after an August 2018 deadline for expert reports had lapsed.


    New Delhi: A federal judge on Wednesday signalled he may strike some new evidence GlaxoSmithKline Plc put forward in its renewed bid to argue federal law preempts state law claims in a case that alleges the company failed to warn that its anti-nausea drug Zofran can cause birth defects.


    Read Also: GSK gets USFDA nod for Nucala, only biologic to treat eosinophilic asthma in the age group 6-11 year


    U.S. District Judge F. Dennis Saylor during a hearing in Boston asked why some of GSK's witnesses should be allowed to put forward new opinions to support the drugmaker's defence after an August 2018 deadline for expert reports had lapsed.


    Read Also: GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore

    F Dennis SaylorGlaxoSmithKlineGSKGSK fightpharmapharma companypharma newsstrikeZofran
    Source : Reuters

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X